| 26/02/2021 |
Sharing learning and driving improvement through regular team meetings |
Coronavirus (COVID-19) |
Principle 1. Governance |
1.2 |
The pharmacy is holding regular clinical governance meetings to help manage the risks associated with providing its services during a national pandemic. It uses these meetings as an opportunity to share learning and to drive improvement. |
Details
|
| 26/02/2021 |
Observation audits contributing to the safe and effective running of a COVID-19 Pharmacy-led vaccination site |
Coronavirus (COVID-19) |
Principle 1. Governance |
1.2 |
The pharmacy is using ongoing observation audits to support the safe and effective running of its COVID-19 vaccination site. It is sharing the learning from these audits to help inform practice and to continually drive improvement. |
Details
|
| 23/01/2021 |
Recording and sharing examples when person-centred care makes a difference to people’s health and wellbeing. |
Coronavirus (COVID-19), Customer and patient focus, Outcomes for patients, Proactive approach |
Principle 1. Governance, Principle 2. Staff |
1.2, 1.8, 2.2, 2.4, 2.5 |
When the actions of pharmacy team members lead to positive health and wellbeing outcomes for people using their services, the team feels empowered to record and share this with the superintendent pharmacist (SI). The SI shares these examples with the other pharmacies within the company to promote shared learning. Recording these events and actions encourages team members to reflect on how the pharmacy meets GPhC standards. This reflective approach helps to support learning, development and confidence and provide good person-centred care. |
Details
|
| 14/04/2020 |
Using near miss data to help manage risk during the COVID-19 pandemic |
Coronavirus (COVID-19) |
Principle 1. Governance |
1.2 |
The pharmacy is able to identify the impact that the increased workload caused by the COVID-19 pandemic is having on the team. It is using its procedures for capturing and reviewing near miss errors so that it can share information and learn from them. And it is adapting its processes to help reduce the risk of making mistakes in future. |
Details
|
| 20/12/2019 |
Application of safety and quality monitoring processes to support shared learning |
Efficiency of processes, Governance, Leadership |
Principle 1. Governance |
1.2 |
Pharmacy team members act openly and honestly by sharing information when mistakes happen. And they engage fully in shared learning processes to help reduce identified risks. |
Details
|
| 20/12/2019 |
Effective shared learning arrangements to improve patient safety. And continual development of the pharmacy team |
Efficiency of processes, Governance, Leadership, Outcomes for patients, Proactive approach, Responsiveness |
Principle 1. Governance, Principle 2. Staff |
1.2, 1.3, 2.2, 2.3 |
The pharmacy has robust safety processes. And its team members are committed to sharing learning to help continuously drive improvement. Pharmacy team members have clearly defined roles and responsibilities. And the pharmacy manages the risks associated with delegating its tasks well, through regular audit. The pharmacy has robust learning and development strategies which encourage pharmacy team members to expand their knowledge and skills. Pharmacy team members demonstrate how they apply their professional judgement and learning by working in specialised roles focussed on improving outcomes for the people using the pharmacy's services. |
Details
|
| 19/08/2019 |
Inadequate identification and management of the risks associated with the provision of medicines to people overseas. |
Customer and patient focus, Governance, Lack of key knowledge and a failure to learn, Leadership, Outcomes for patients |
Principle 1. Governance, Principle 3. Premises, Principle 4. Services, including medicines management |
1.1, 1.2, 1.3, 1.6, 1.8, 3.1, 4.2, 4.3 |
The pharmacy does not adequately identify and manage the risks associated with the provision of medicines to people overseas. It does not check the identity of patients, or ensure that higher‐risk medicines, including methotrexate and misoprostol, are supplied safely. Pharmacy professionals involved in the supply of medicines overseas do not fully understand their responsibilities or accountabilities. The pharmacy does not make accurate or complete records about the supplies it makes of prescription‐only medicines to patients overseas. It also does not adequately monitor the temperature of medicines which require cold storage. |
Details
|
| 15/08/2019 |
Efficiency and safety of processes assured through sound risk assessment and use of staff skills. |
Customer and patient focus, Efficiency of processes, Governance, Innovation, Leadership, Outcomes for patients, Proactive approach, Responsiveness |
Principle 1. Governance |
1.1, 1.2, 1.3, 1.6 |
There is an innovative approach taken to using the Accuracy Checking Technician’s skills, enhanced use of the pharmacy team and thorough and robust record keeping to free up pharmacists’ time to deliver additional services safely, while ensuring that the dispensing and supply of medicines remains safe, and compliance and medicines optimisation is addressed. |
Details
|
| 09/08/2019 |
Effective use of monitoring and review mechanisms and a culture of learning from incidents. |
Customer and patient focus, Efficiency of processes, Governance, Leadership, Proactive approach |
Principle 1. Governance |
1.1, 1.2 |
The pharmacy demonstrates a robust and systematic approach to clinical governance. Risks to pharmacy services are proactively identified and managed. Systematic review procedures are applied with risk reduction actions implemented routinely. |
Details
|
| 09/08/2019 |
Inadequate arrangements for learning from mistakes and errors. |
Governance, Lack of key knowledge and a failure to learn |
Principle 1. Governance |
1.2 |
The pharmacy team doesn't have any procedures to follow to make sure they adequately respond to mistakes. And they don't record mistakes or review why they happened. So, they do not have the information to identify patterns and help reduce similar mistakes in the future. |
Details
|
| 26/07/2019 |
Identification and management of risks to dispensing processes |
Efficiency of processes, Governance, Innovation |
Principle 1. Governance |
1.1, 1.2 |
The pharmacy applies systematic processes when delivering all its services. These processes are continually monitored and used to drive up standards. The pharmacy uses innovative technology to substantially reduce risks to patient safety. It has a strong culture of sharing learning with its team, and with other healthcare organisations. This helps to ensure its services are always provided safely. |
Details
|
| 25/07/2019 |
Collaborative working with other health services |
Added value, Customer and patient focus, Efficiency of processes, Governance, Innovation, Leadership, Outcomes for patients, Proactive approach, Responsiveness |
Principle 1. Governance, Principle 4. Services, including medicines management |
1.1, 1.2, 4.2 |
Integrated governance procedures are in place which improve patient outcomes and patient safety. Collaborative procedures are in place with other healthcare providers and wider community groups. The pharmacy had a strong focus on medicines optimisation and proactively identified and managed potential risks to patients. |
Details
|
| 25/07/2019 |
Comprehensive monitoring and review mechanisms to minimise risks |
Customer and patient focus, Efficiency of processes, Governance, Leadership, Proactive approach |
Principle 1. Governance |
1.1, 1.2 |
There is a consistent and high quality proactive approach to minimise risk across all aspects of pharmacy service delivery. Dispensing accuracy is continually monitored and reviewed with attention given to avoiding repetition and this is shared across the organisation. All services are reviewed on an ongoing basis and changes made to ensure continuing effectiveness and safety. |
Details
|
| 24/07/2019 |
Effective use of risk assessments to identify potential patient safety risks. |
Added value, Customer and patient focus, Governance, Innovation, Leadership, Outcomes for patients, Proactive approach, Responsiveness |
Principle 1. Governance |
1.1, 1.2 |
All services are risk assessed before commencing, and on an ongoing basis to ensure that risks are managed. There is awareness of potentially weaker areas in processes, so strategies including doublechecking and additional audits are in place to manage these. There is very thorough record-keeping and checking of high-risk activities. Improvements have been demonstrated by making comparisons after new services and technology are introduced with previous arrangements. |
Details
|
| 19/07/2019 |
Comprehensive monitoring and review mechanisms to minimise risks supported by a learning culture |
Efficiency of processes, Governance, Leadership, Proactive approach |
Principle 1. Governance |
1.1, 1.2 |
Near miss records and errors are consistently reviewed to improve the safety and quality of services. |
Details
|
| 19/07/2019 |
Effective use of monitoring and review mechanisms and a culture of learning from incidents. |
Customer and patient focus, Efficiency of processes, Governance, Leadership, Proactive approach |
Principle 1. Governance |
1.1, 1.2 |
Dispensing accuracy is constantly monitored and reviewed and there is a robust system in place to deal with, discuss and improve practice following incidents. There is evidence that the pharmacy team seek to identify, manage and minimise risks with trends being analysed. |
Details
|
| 19/07/2019 |
Segregation of different dispensing services |
Added value, Customer and patient focus, Efficiency of processes, Governance, Leadership, Outcomes for patients, Proactive approach |
Principle 1. Governance, Principle 4. Services, including medicines management |
1.1, 1.2, 4.2 |
The pharmacy demonstrates a robust and systematic approach to clinical governance. Risks are proactively identified and managed through a variety of working procedures. There is a strong culture of shared learning and risk reduction actions being applied in the pharmacy due to systematic review processes in place. Staff demonstrate a clear understanding of their roles and these are documented within SOPs. |
Details
|
| 19/07/2019 |
Effective use of monitoring and review mechanisms and a culture of learning from incidents. |
Efficiency of processes, Governance |
Principle 1. Governance |
1.2 |
Practices and procedures are monitored on an ongoing basis and action is taken so that risks are managed and services improve. |
Details
|
| 19/07/2019 |
Effective use of monitoring and review mechanisms and a culture of learning from incidents. |
Efficiency of processes, Governance, Leadership, Proactive approach |
Principle 1. Governance |
1.2 |
Continual review mechanisms are used to identify patterns or trends and establish individual coaching needs. |
Details
|
| 19/07/2019 |
Management of high risk services and a culture of continuous learning |
Customer and patient focus, Efficiency of processes, Governance, Leadership |
Principle 1. Governance, Principle 4. Services, including medicines management |
1.1, 1.2, 1.3, 1.6, 4.2 |
High-risk activities are proactively identified and the risks effectively managed, including risks to patients receiving the substance misuse service. Systematic monitoring and review mechanisms are in place demonstrating a culture of continuous learning, including the annual objective review of SOPs and sharing of learning. There is clear role definition and the pharmacy manages risk when tasks are delegated to members of the team. |
Details
|
